| Primary |
| Drug Use For Unknown Indication |
16.8% |
| Acute Myeloid Leukaemia |
15.3% |
| Myelodysplastic Syndrome |
14.7% |
| Prophylaxis |
8.2% |
| Hypertension |
6.6% |
| Nausea |
5.6% |
| Constipation |
5.1% |
| Antifungal Prophylaxis |
4.4% |
| Thrombocytopenia |
2.8% |
| Antiviral Prophylaxis |
2.6% |
| Insomnia |
2.3% |
| Mycosis Fungoides |
2.1% |
| Benign Prostatic Hyperplasia |
1.8% |
| Neutropenia |
1.8% |
| Pneumonia |
1.8% |
| Neutropenic Sepsis |
1.6% |
| Premedication |
1.6% |
| Product Used For Unknown Indication |
1.6% |
| Antiemetic Supportive Care |
1.5% |
| Coagulopathy |
1.5% |
|
| Febrile Neutropenia |
19.7% |
| Pneumonia |
19.0% |
| Death |
6.8% |
| Sepsis |
5.4% |
| Thrombocytopenia |
5.4% |
| Neutropenia |
4.8% |
| Pyrexia |
4.1% |
| White Blood Cell Count Decreased |
4.1% |
| Hypotension |
3.4% |
| Renal Failure Acute |
3.4% |
| Dyspnoea |
2.7% |
| Infection |
2.7% |
| Pain |
2.7% |
| Pancytopenia |
2.7% |
| Pleural Effusion |
2.7% |
| Abdominal Pain |
2.0% |
| Acute Myeloid Leukaemia |
2.0% |
| Ascites |
2.0% |
| Cellulitis |
2.0% |
| Cerebral Haemorrhage |
2.0% |
|
| Secondary |
| Myelodysplastic Syndrome |
14.1% |
| Acute Myeloid Leukaemia |
11.2% |
| Breast Cancer |
10.6% |
| Drug Use For Unknown Indication |
10.3% |
| Hodgkin's Disease |
10.2% |
| Lung Neoplasm Malignant |
10.2% |
| Non-hodgkin's Lymphoma |
10.1% |
| Product Used For Unknown Indication |
4.7% |
| Prophylaxis |
4.5% |
| Hypertension |
2.6% |
| Constipation |
1.6% |
| Nausea |
1.6% |
| Pain |
1.5% |
| Antifungal Prophylaxis |
1.3% |
| Chronic Lymphocytic Leukaemia |
1.1% |
| Thrombocytopenia |
1.1% |
| Chronic Myeloid Leukaemia |
0.9% |
| Chronic Myelomonocytic Leukaemia |
0.8% |
| Lymphoma |
0.8% |
| Neutropenia |
0.8% |
|
| Febrile Neutropenia |
14.1% |
| Pneumonia |
14.1% |
| White Blood Cell Count Decreased |
6.8% |
| Sepsis |
5.2% |
| Pulmonary Fibrosis |
4.7% |
| Acute Myeloid Leukaemia |
4.2% |
| Diarrhoea |
4.2% |
| First Trimester Pregnancy |
4.2% |
| Neutropenia |
4.2% |
| Rash |
4.2% |
| Septic Shock |
4.2% |
| Hypotension |
3.7% |
| Lung Infection |
3.7% |
| Platelet Count Decreased |
3.7% |
| Respiratory Failure |
3.7% |
| Neutrophil Count Decreased |
3.1% |
| Pneumonitis |
3.1% |
| Pyrexia |
3.1% |
| Thrombocytopenia |
3.1% |
| Anaemia |
2.6% |
|
| Concomitant |
| Myelodysplastic Syndrome |
19.3% |
| Product Used For Unknown Indication |
14.5% |
| Acute Myeloid Leukaemia |
13.4% |
| Prophylaxis |
10.2% |
| Pain |
5.6% |
| Iron Overload |
4.8% |
| Infection Prophylaxis |
4.3% |
| Biopsy Bone Marrow |
3.2% |
| Premedication |
3.2% |
| Bone Marrow Conditioning Regimen |
2.7% |
| Prophylaxis Against Graft Versus Host Disease |
2.4% |
| Dental Disorder Prophylaxis |
2.1% |
| Hyperuricaemia |
2.1% |
| Intravenous Catheter Management |
2.1% |
| Prophylaxis Of Nausea And Vomiting |
1.9% |
| Antacid Therapy |
1.6% |
| Cardiovascular Disorder |
1.6% |
| Clostridial Infection |
1.6% |
| Diarrhoea |
1.6% |
| Dyspepsia |
1.6% |
|
| Nausea |
14.8% |
| Acute Myeloid Leukaemia |
9.8% |
| Therapeutic Response Decreased |
6.6% |
| Venous Thrombosis |
6.6% |
| White Blood Cell Count Decreased |
6.6% |
| Drug Ineffective |
4.9% |
| Myelofibrosis |
4.9% |
| Pyrexia |
4.9% |
| Renal Failure |
4.9% |
| Thrombocytopenia |
4.9% |
| Febrile Neutropenia |
3.3% |
| Generalised Oedema |
3.3% |
| Lung Disorder |
3.3% |
| No Therapeutic Response |
3.3% |
| Platelet Count Decreased |
3.3% |
| Pneumonia |
3.3% |
| Pseudomonal Sepsis |
3.3% |
| Staphylococcal Infection |
3.3% |
| Weight Decreased |
3.3% |
| Abdominal Discomfort |
1.6% |
|
